Decreased strongyle egg re-appearance period after treatment with ivermectin and moxidectin in horses in Belgium, Italy and The Netherlands.
- Journal Article
Summary
The research is focused on studying the effectiveness of two drugs, ivermectin and moxidectin, on treating digestive system parasites in horses. The study shows a high efficacy in reducing the faecal egg count for both drugs. However, the study also reveals a reduction in the egg reappearance period after treatment in more than half of the study sites.
Explanation of the Study
This study aimed to evaluate the efficacy of ivermectin (IVM) and moxidectin (MOX), two anthelmintics, in treating gastro-intestinal strongyles (a type of roundworm) in horses. This was measured by:
- Performing a faecal egg count reduction test (FECRT) to assess the decrease in parasite eggs after treatment
- Monitoring the egg reappearance period (ERP), defining how long it takes for the eggs to reappear in the faecal matter after treatment
This was a field efficacy study, conducted in Belgium, Italy, and The Netherlands with a randomized complete block design at each study site.
The Horses were divided into two groups based on their initial faecal egg counts (FEC). They were then treated with either IVM or MOX. Post-treatment, faecal samples were collected from the horses regularly for different durations based on the treatment they received—56 days for IVM and 84 days for MOX.
Findings of the Study
The research encompassed 320 horses across 32 farms. Two weeks after administering the drugs, the FECRT showed a 100% reduction in 59 out of the 64 treatment groups, and more than 92% efficacy in the remaining five.
However, the research also found that the ERP was shortened in at least one of the treatments in 17 of the 32 study sites. On 9 of those sites, both drugs resulted in a decreased ERP. In certain locations where a decrease in ERP was recorded, there was also a drop in efficacy at the end of the expected ERP.
The study also found cases where the efficacy of the drugs was below 90% as soon as the 42nd or 56th day after treatment.
Summary of Findings
Though the study demonstrated a high efficacy of MOX and IVM in a faecal egg count reduction test 14 days after treatment, it also pointed out a shortened egg reappearance period at more than half of the selected study sites. This implies that while these treatments may be highly effective in terms of initial parasite clearance, their long-term effectiveness might be compromised. The study’s revelations about these drugs’ shortened ERP could have implications for how they are used in veterinary practice for parasite control in horses.
Cite This Article
Publication
Researcher Affiliations
- Zoetis, Mercuriuslaan 20, 1930 Zaventem, Belgium. Electronic address: thomasgeurden@yahoo.com.
- Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 1, 3584 CL Utrecht, The Netherlands.
- Laboratory for Parasitology, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 9820 Merelbeke, Belgium.
- Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 1, 3584 CL Utrecht, The Netherlands.
- Zoetis, Mercuriuslaan 20, 1930 Zaventem, Belgium.
- Laboratory for Parasitology, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 9820 Merelbeke, Belgium.
- Zoetis, Mercuriuslaan 20, 1930 Zaventem, Belgium.
- Zoetis, Mercuriuslaan 20, 1930 Zaventem, Belgium.
- Department of Animal Medicine, Production and Health, University of Padova, Viale dell'Università 16, 35020 Legnaro, PD, Italy.
- Faculty of Veterinary Medicine, University of Udine, Via delle Scienze 206, 33100 Udine, Italy.
- Faculty of Veterinary Medicine, University of Teramo, Piazza A. Moro 45, 64100 Teramo, Italy.
- Faculty of Veterinary Medicine, University of Teramo, Piazza A. Moro 45, 64100 Teramo, Italy.
MeSH Terms
- Animals
- Anthelmintics / therapeutic use
- Belgium / epidemiology
- Feces / parasitology
- Female
- Horse Diseases / drug therapy
- Horse Diseases / epidemiology
- Horses
- Italy / epidemiology
- Ivermectin / therapeutic use
- Macrolides / therapeutic use
- Netherlands / epidemiology
- Parasite Egg Count / veterinary
- Strongyle Infections, Equine / drug therapy
- Strongyle Infections, Equine / epidemiology
Citations
This article has been cited 17 times.- Bull KE, Allen KJ, Hodgkinson JE, Peachey LE. The first report of macrocyclic lactone resistant cyathostomins in the UK.. Int J Parasitol Drugs Drug Resist 2023 Apr;21:125-130.
- Macdonald SL, Abbas G, Ghafar A, Gauci CG, Bauquier J, El-Hage C, Tennent-Brown B, Wilkes EJA, Beasley A, Jacobson C, Cudmore L, Carrigan P, Hurley J, Beveridge I, Hughes KJ, Nielsen MK, Jabbar A. Egg reappearance periods of anthelmintics against equine cyathostomins: The state of play revisited.. Int J Parasitol Drugs Drug Resist 2023 Apr;21:28-39.
- Baranova MV, Panova OA, Polukhina DN, Panova DS. Reduction of the nematode egg reappearance period in horses after anthelmintic therapy.. Vet World 2022 Jun;15(6):1530-1534.
- Abbas G, Ghafar A, Hurley J, Bauquier J, Beasley A, Wilkes EJA, Jacobson C, El-Hage C, Cudmore L, Carrigan P, Tennent-Brown B, Gauci CG, Nielsen MK, Hughes KJ, Beveridge I, Jabbar A. Cyathostomin resistance to moxidectin and combinations of anthelmintics in Australian horses.. Parasit Vectors 2021 Dec 4;14(1):597.
- Zanet S, Battisti E, Labate F, Oberto F, Ferroglio E. Reduced Efficacy of Fenbendazole and Pyrantel Pamoate Treatments against Intestinal Nematodes of Stud and Performance Horses.. Vet Sci 2021 Mar 5;8(3).
- Dauparaitė E, Kupčinskas T, von Samson-Himmelstjerna G, Petkevičius S. Anthelmintic resistance of horse strongyle nematodes to ivermectin and pyrantel in Lithuania.. Acta Vet Scand 2021 Jan 25;63(1):5.
- Roelfstra L, Quartier M, Pfister K. Preliminary Data from Six Years of Selective Anthelmintic Treatment on Five Horse Farms in France and Switzerland.. Animals (Basel) 2020 Dec 15;10(12).
- Nielsen MK, Banahan M, Kaplan RM. Importation of macrocyclic lactone resistant cyathostomins on a US thoroughbred farm.. Int J Parasitol Drugs Drug Resist 2020 Dec;14:99-104.
- Leathwick DM, Sauermann CW, Nielsen MK. Managing anthelmintic resistance in cyathostomin parasites: Investigating the benefits of refugia-based strategies.. Int J Parasitol Drugs Drug Resist 2019 Aug;10:118-124.
- Sanna G, Pipia AP, Tamponi C, Manca R, Varcasia A, Traversa D, Scala A. Anthelmintics efficacy against intestinal strongyles in horses of Sardinia, Italy.. Parasite Epidemiol Control 2016 Jun;1(2):15-19.
- Sallé G, Kornaś S, Basiaga M. Equine strongyle communities are constrained by horse sex and species dipersal-fecundity trade-off.. Parasit Vectors 2018 May 2;11(1):279.
- Clark A, Sallé G, Ballan V, Reigner F, Meynadier A, Cortet J, Koch C, Riou M, Blanchard A, Mach N. Strongyle Infection and Gut Microbiota: Profiling of Resistant and Susceptible Horses Over a Grazing Season.. Front Physiol 2018;9:272.
- Hernández JA, Vázquez-Ruiz RA, Cazapal-Monteiro CF, Valderrábano E, Arroyo FL, Francisco I, Miguélez S, Sánchez-Andrade R, Paz-Silva A, Arias MS. Isolation of Ovicidal Fungi from Fecal Samples of Captive Animals Maintained in a Zoological Park.. J Fungi (Basel) 2017 Jun 2;3(2).
- Molena RA, Peachey LE, Di Cesare A, Traversa D, Cantacessi C. Cyathostomine egg reappearance period following ivermectin treatment in a cohort of UK Thoroughbreds.. Parasit Vectors 2018 Jan 25;11(1):61.
- Sallé G, Cortet J, Bois I, Dubès C, Guyot-Sionest Q, Larrieu C, Landrin V, Majorel G, Wittreck S, Woringer E, Couroucé A, Guillot J, Jacquiet P, Guégnard F, Blanchard A, Leblond A. Risk factor analysis of equine strongyle resistance to anthelmintics.. Int J Parasitol Drugs Drug Resist 2017 Dec;7(3):407-415.
- Zak A, Siwinska N, Slowikowska M, Borowicz H, Kubiak K, Hildebrand J, Popiolek M, Niedzwiedz A. Searching for ivermectin resistance in a Strongylidae population of horses stabled in Poland.. BMC Vet Res 2017 Jul 3;13(1):210.
- Schneider S, Pfister K, Becher AM, Scheuerle MC. Strongyle infections and parasitic control strategies in German horses - a risk assessment.. BMC Vet Res 2014 Nov 12;10:262.